tiprankstipranks
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
US Market
INTI
Inhibitor Therapeutics
RESEARCH TOOLSreports

Inhibitor Therapeutics (INTI) Financial Statements

30 Followers

Inhibitor Therapeutics Financial Overview

Inhibitor Therapeutics's market cap is currently $15.53M. The company's EPS TTM is $-0.019; its P/E ratio is -2.35; Inhibitor Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -3.43M$ -3.66M$ -3.40M$ -658.00K$ -325.00K
EBITDA$ -3.43M$ 318.00K$ 378.84K$ -74.00$ -325.00K
Net Income$ -3.30M$ -3.34M$ -3.03M$ 12.11M$ -299.00K
Balance Sheet
Cash & Short-Term Investments$ 2.38M$ 5.61M$ 8.84M$ 11.95M$ 30.63K
Total Assets$ 2.51M$ 5.69M$ 8.95M$ 11.98M$ 58.78K
Total Debt$ 61.61K$ 0.00$ 0.00$ 411.00K$ 231.00K
Net Debt$ -2.31M$ -5.61M$ -8.84M$ -11.54M$ 200.37K
Total Liabilities$ 3.80M$ 3.71M$ 3.67M$ 3.68M$ 3.68M
Stockholders' Equity$ -1.29M$ 1.99M$ 5.28M$ 8.30M$ -3.62M
Cash Flow
Free Cash Flow$ -3.23M$ -3.23M$ -2.70M$ 11.74M$ -220.43K
Operating Cash Flow$ -3.23M$ -3.23M$ -2.70M$ 11.74M$ -220.43K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 0.00$ -411.00K$ 180.00K$ 176.00K
Currency in USD

Inhibitor Therapeutics Earnings and Revenue History

Income Statement >

Inhibitor Therapeutics Debt to Assets

Balance Sheet >

Inhibitor Therapeutics Cash Flow

Cash Flow >

Inhibitor Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >